These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1028 related items for PubMed ID: 17911197
1. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N. Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197 [Abstract] [Full Text] [Related]
7. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, Batun S, Isi H. Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893 [Abstract] [Full Text] [Related]
8. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Kim RJ, Becker RC. Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985 [Abstract] [Full Text] [Related]
10. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J. Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075 [Abstract] [Full Text] [Related]
16. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism]. Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont'ev SG, Petukhov EB, Kubatiev AA, Savel'ev VS. Ter Arkh; 2006 Jan; 78(6):70-6. PubMed ID: 16881367 [Abstract] [Full Text] [Related]